<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">35418791</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>15</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Print">1179-5476</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>15</Volume>
            <PubDate>
              <Year>2022</Year>
            </PubDate>
          </JournalIssue>
          <Title>Clinical medicine insights. Case reports</Title>
          <ISOAbbreviation>Clin Med Insights Case Rep</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Novel Melano-Cortin-2-Receptor Gene Mutation Presenting With Infantile Cholestasis: A Case Report.</ArticleTitle>
        <Pagination>
          <StartPage>11795476221091387</StartPage>
          <MedlinePgn>11795476221091387</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">11795476221091387</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1177/11795476221091387</ELocationID>
        <Abstract>
          <AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">For many years, congenital panhypopituitarism has been recognized to cause infantile cholestasis. However, the isolated cortisol deficiency as a cause of cholestasis and liver failure was rarely reported.</AbstractText>
          <AbstractText Label="CASE DESCRIPTION" NlmCategory="UNASSIGNED">A 32-days old male infant presented to the hepatology clinic with infantile cholestasis. His initial workup revealed alanine transaminase (ALT) level of 138 U/L, aspartate transaminase level of 76 U/L, total bilirubin (T.Bil) of 103 mmol/L, direct bilirubin of (D.Bil) 83 mmol/L, gamma-glutamyl transpeptidase (GGT) level of 28 U/L with normal prothrombin time (PT) of 13 seconds. One week later, the patient developed severe bronchiolitis necessitating mechanical ventilation associated with acute liver failure and worsening cholestasis. His ALT increased to 303.5 U/L and direct bilirubin increased to 204 mmol/L with prolongation of PT to 18.9 seconds reflecting derangement in synthetic liver functions. There was associated hypoglycemia, hyponatremia and high normal potassium level with a picture of adrenal insufficiency. Hormonal workup and genetic testing revealed isolated cortisol deficiency with a novel homozygous mutation c.763_764delAT (p. Met255ValfsX17) in Melanocortin 2 receptor gene (<i>MC2R</i>) and the patient was diagnosed as familial primary glucocorticoid deficiency. The patient was maintained on cortisol replacement therapy with the resolution of cholestasis and normalization of liver functions.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Patients presenting with infantile cholestasis associated with documented hypoglycemia should alert pediatricians about the possibility of familial glucocorticoid deficiency and prompt investigation of adrenal function should be considered. Cortisol replacement therapy leads to the resolution of cholestasis.</AbstractText>
          <CopyrightInformation>© The Author(s) 2022.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Alsaedi</LastName>
            <ForeName>Abdulaziz</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Consultant Pediatric Endocrinologist, Alhada Armed Forces Hospital, Taif, Saudi Arabia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kamal</LastName>
            <ForeName>Naglaa M</ForeName>
            <Initials>NM</Initials>
            <Identifier Source="ORCID">0000-0002-8535-3838</Identifier>
            <AffiliationInfo>
              <Affiliation>Professor of Pediatrics and Pediatric Hepatology, Faculty of Medicine, Cairo University, Egypt.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bakkar</LastName>
            <ForeName>Ayman</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Consultant Pediatric Endocrinologist, Alhada Armed Forces Hospital, Taif, Saudi Arabia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Althobaiti</LastName>
            <ForeName>Enad</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Pediatric Endocrinology Senior Registrar, Alhada Military Hospital, Taif, Saudi Arabia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Naeem</LastName>
            <ForeName>Muhammad</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Alhada Military Hospital, Taif, Saudi Arabia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kamal</LastName>
            <ForeName>Mohamed</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Alhada Military Hospital, Taif, Saudi Arabia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>04</Month>
          <Day>08</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Clin Med Insights Case Rep</MedlineTA>
        <NlmUniqueID>101531893</NlmUniqueID>
        <ISSNLinking>1179-5476</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Cholestasis</Keyword>
        <Keyword MajorTopicYN="N">familial glucocorticoid deficiency</Keyword>
        <Keyword MajorTopicYN="N">hypoglycemia</Keyword>
        <Keyword MajorTopicYN="N">infant</Keyword>
      </KeywordList>
      <CoiStatement>Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>2</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>9</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>14</Day>
          <Hour>5</Hour>
          <Minute>20</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35418791</ArticleId>
        <ArticleId IdType="pmc">PMC8998368</ArticleId>
        <ArticleId IdType="doi">10.1177/11795476221091387</ArticleId>
        <ArticleId IdType="pii">10.1177_11795476221091387</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>
Jazayeri O, Liu X, van Diemen CC, et al.. A novel homozygous insertion and review of published mutations in the NNT gene causing familial glucocorticoid deficiency (FGD). Eur J Med Genet. 2015;58:642-649.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26548497</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Abuduxikuer K, Li ZD, Xie XB, Li YC, Zhao J, Wang JS.
Novel melanocortin 2 receptor variant in a Chinese infant with familial glucocorticoid deficiency type 1, case report and review of literature. Front Endocrinol (Lausanne). 2019;6:359.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6563654</ArticleId>
            <ArticleId IdType="pubmed">31244773</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Chung TT, Chan LF, Metherell LA, Clark AJ.
Phenotypic characteristics of familial glucocorticoid deficiency (FGD) type 1 and 2. Clin Endocrinol. 2010;72:589-594.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2855830</ArticleId>
            <ArticleId IdType="pubmed">19558534</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Clark AJ, McLoughlin L, Grossman A.
Familial glucocorticoid deficiency associated with point mutation in the adrenocorticotropin receptor. Lancet. 1993;341:461-462.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8094489</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Tsigos C, Arai K, Hung W, Chrousos GP.
Hereditary isolated glucocorticoid deficiency is associated with abnormalities of the adrenocorticotropin receptor gene. J Clin Invest. 1993;92:2458-2461.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC288430</ArticleId>
            <ArticleId IdType="pubmed">8227361</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Akin MA, Akin L, Coban D, Ozturk MA, Bircan R, Kurtoglu S.
A novel mutation in the MC2R gene causing familial glucocorticoid deficiency type 1. Neonatology. 2011;100:277-281.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21701219</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Chung TT, Webb TR, Chan LF, et al.. The majority of adrenocorticotropin receptor (melanocortin 2 receptor) mutations found in familial glucocorticoid deficiency type 1 lead to defective trafficking of the receptor to the cell surface. J Clin Endocrinol Metab. 2008;93:4948-4954.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2635546</ArticleId>
            <ArticleId IdType="pubmed">18840636</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Mazur A, Koehler K, Schuelke M, Skunde M, Ostanski M, Huebner A.
Familial glucocorticoid deficiency type 1 due to a novel compound heterozygous MC2R mutation. Horm Res. 2008;69:363-368.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18504396</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Ellaway CJ, Silinik M, Cowell CT, et al.. Cholestatic jaundice and congenital hypopituitarism. J Paediatr Child Health. 1995;31:51-53.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7748692</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Leblanc A, Odièvre M, Hadchouel M, Gendrel D, Chaussain JL, Rappaport R.
Neonatal cholestasis and hypoglycemia: possible role of cortisol deficiency. J Pediatr. 1981;99:577-580.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7277099</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Gönç EN, Kandemir N, Andiran N, Ozön A, Yordam N.
Cholestatic hepatitis as a result of severe cortisol deficiency in early infancy: report of two cases and review of literature. Turk J Pediatr. 2006;48:376-379.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17290578</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Al-Hussaini A, Almutairi A, Mursi A, Alghofely M, Asery A.
Isolated cortisol deficiency: a rare cause of neonatal cholestasis. Saudi J Gastroenterol. 2012;18:339-341.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3500024</ArticleId>
            <ArticleId IdType="pubmed">23006463</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Habeb AM, Hughes CR, Al-Arabi R, Al-Muhamadi A, Clark AJ, Metherell LA.
Familial glucocorticoid deficiency: a diagnostic challenge during acute illness. Eur J Pediatr. 2013;172:1407-1410.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23708259</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
National Library of Medicine. NM_000529.2(MC2R). Accessed March 31, 2022. https://www.ncbi.nlm.nih.gov/clinvar/?term=NM_000529.2</Citation>
        </Reference>
        <Reference>
          <Citation>
Braslavsky D, Keselman A, Galoppo M, et al.. Neonatal cholestasis in congenital pituitary hormone deficiency and isolated hypocortisolism: characterization of liver dysfunction and follow-up. Arq Bras Endocrinol Metabol. 2011;55:622-627.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22218445</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Spray CH1, Mckiernan P, Waldron KE, Shaw N, Kirk J, Kelly DA. Investigation and outcome of neonatal hepatitis in infants with hypopituitarism. Acta Paediatr. 2000;89:951-954.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10976837</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
